Mirum Pharmaceuticals Inc (MIRM)
46.26
+2.34
(+5.33%)
USD |
NASDAQ |
Nov 14, 16:00
48.11
+1.85
(+4.00%)
After-Hours: 06:58
Mirum Pharmaceuticals Cash and Short Term Investments (Quarterly): 278.37M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 278.37M |
| March 31, 2024 | 302.84M |
| December 31, 2023 | 286.33M |
| September 30, 2023 | 306.03M |
| June 30, 2023 | 329.95M |
| March 31, 2023 | 132.07M |
| December 31, 2022 | 151.72M |
| September 30, 2022 | 185.35M |
| June 30, 2022 | 124.95M |
| March 31, 2022 | 139.91M |
| December 31, 2021 | 156.54M |
| Date | Value |
|---|---|
| September 30, 2021 | 190.03M |
| June 30, 2021 | 223.85M |
| March 31, 2021 | 213.11M |
| December 31, 2020 | 231.82M |
| September 30, 2020 | 133.75M |
| June 30, 2020 | 149.34M |
| March 31, 2020 | 159.53M |
| December 31, 2019 | 116.66M |
| September 30, 2019 | 126.26M |
| June 30, 2019 | 84.19M |
| March 31, 2019 | 49.49M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
116.66M
Minimum
Dec 2019
329.95M
Maximum
Jun 2023
200.64M
Average
185.35M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 330.56M |
| Cytokinetics Inc | 1.012B |
| Amicus Therapeutics Inc | 249.76M |
| MannKind Corp | 251.59M |
| TG Therapeutics Inc | 341.04M |